In regard to Padula et al., normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. IJROBP 2002;52: 439-443

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):981; author reply 981. doi: 10.1016/s0360-3016(02)03001-8.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Goserelin / therapeutic use
  • Humans
  • Leuprolide / therapeutic use
  • Luteinizing Hormone / blood
  • Male
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / radiotherapy
  • Radiotherapy, Conformal
  • Reference Values
  • Testosterone / blood*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal
  • Goserelin
  • Gonadotropin-Releasing Hormone
  • Testosterone
  • Luteinizing Hormone
  • Leuprolide